Robot Mends Hearts in Britain

A remote-controlled robot helps British surgeons repair heart defects.

By | October 24, 2012

Wikimedia, NIHSurgeons at the New Cross Hospital in Wolverhampton, United Kingdom, performed the country’s first robotic-assisted heart surgeries using a $1.6 million remote-controlled robot, called Da Vinci, according to a news story published yesterday (October 22) by the BBC. In one of the robot-assisted surgeries, a young woman, Natalie Jones of Stourbridge, had a 1.3-inch hole repaired in her heart. In a second surgery, the robot repaired the valve between the left atrium and ventricle of a middle-aged man, Paul Whitehouse from Halesowen.

Finland and Sweden are the only other countries in Europe to perform robotic heart surgery, while surgeons in America performed their first robot-assisted heart surgery in 1999.

While conventional heart surgery requires opening the whole breastplate, surgery using Da Vinci requires only incisions between the ribs, and doctors say the surgery over-all is safer and the patients recover faster. “There is less pain and patients are able to return home to their normal activities far sooner,” heart surgeon Stephen Billing, who was involved in both surgeries, told the BBC. The remote-controlled robot can make precise motions—moving just 1 mm for every 3 mm that the doctors move their hands—and surgeons have a 3-dimensional view of a patient’s heart throughout the procedure.

But, robotic surgery comes with a large price tag. The initial cost of the robot was nearly $1.6 million and its four arms, which cost more than $3,000 each, need to be replaced every 10 surgeries. Additionally, the two surgeons, Billing and Moninder Bhabra, went through thorough training in Finland beforehand.

Despite the price tag, the team plans to use Da Vinci to repair 30 mitral valves a year at New Cross. “I accept money is tight within the NHS [National Health Service], but we can't be left behind by the rest of the world in developing what we are doing in surgery and other aspects of health care," Bhabra told the BBC.


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham